Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, and the use of glucocorticoids in clinical practice is controversial. Our clinical experiences with glucocorticoid treatment suggested that, while use was effective in some cases, in other cases, glucocorticoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yong, Chen, Yan, Li, Yingchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943439/
https://www.ncbi.nlm.nih.gov/pubmed/33718395
http://dx.doi.org/10.3389/fmed.2021.564943
_version_ 1783662492715581440
author Guo, Yong
Chen, Yan
Li, Yingchuan
author_facet Guo, Yong
Chen, Yan
Li, Yingchuan
author_sort Guo, Yong
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, and the use of glucocorticoids in clinical practice is controversial. Our clinical experiences with glucocorticoid treatment suggested that, while use was effective in some cases, in other cases, glucocorticoid were ineffective and even resulted in immunosuppression that could lead to deterioration. Therefore, glucocorticoids should be used with caution in patients with SARS-CoV-2.
format Online
Article
Text
id pubmed-7943439
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79434392021-03-11 Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2 Guo, Yong Chen, Yan Li, Yingchuan Front Med (Lausanne) Medicine Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, and the use of glucocorticoids in clinical practice is controversial. Our clinical experiences with glucocorticoid treatment suggested that, while use was effective in some cases, in other cases, glucocorticoid were ineffective and even resulted in immunosuppression that could lead to deterioration. Therefore, glucocorticoids should be used with caution in patients with SARS-CoV-2. Frontiers Media S.A. 2021-02-24 /pmc/articles/PMC7943439/ /pubmed/33718395 http://dx.doi.org/10.3389/fmed.2021.564943 Text en Copyright © 2021 Guo, Chen and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Guo, Yong
Chen, Yan
Li, Yingchuan
Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
title Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
title_full Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
title_fullStr Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
title_full_unstemmed Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
title_short Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
title_sort glucocorticoids should be used with caution in patients with sars-cov-2
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943439/
https://www.ncbi.nlm.nih.gov/pubmed/33718395
http://dx.doi.org/10.3389/fmed.2021.564943
work_keys_str_mv AT guoyong glucocorticoidsshouldbeusedwithcautioninpatientswithsarscov2
AT chenyan glucocorticoidsshouldbeusedwithcautioninpatientswithsarscov2
AT liyingchuan glucocorticoidsshouldbeusedwithcautioninpatientswithsarscov2

Ejemplares similares